Patent details
EP3833690 Title: RECOMBINANT BIFUNCTIONAL PROTEIN TARGETING CD47 AND HER2
Basic Information
- Publication number:
- EP3833690
- PCT Application Number:
- CN2019099530
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP198479644
- PCT Publication Number:
- WO2020029982
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- RECOMBINANT BIFUNCTIONAL PROTEIN TARGETING CD47 AND HER2
- French Title of Invention:
- PROTÉINE BIFONCTIONNELLE RECOMBINANTE CIBLANT CD47 ET HER2
- German Title of Invention:
- GEGEN CD47 UND HER2 GERICHTETES, REKOMBINANTES BIFUNKTIONALES PROTEIN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 25/04/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 06/05/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 27/03/2024
- Unitary Effect Registration Date:
- 06/05/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 06/08/2019
- Grant date:
- 27/03/2024
- EP Publication Date:
- 16/06/2021
- PCT Publication Date:
- 13/02/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 27/03/2024
- EP B1 Publication Date:
- 27/03/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 06/08/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 20/03/2024
- Name:
- ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- Address:
- Building 15, Lane 1000, Zhangheng Road, Pudong New Area, Shanghai 201203, China (CN)
Inventor
1
- Name:
- LI, Song
- Address:
- China (CN)
2
- Name:
- TIAN, Wenzhi
- Address:
- China (CN)
Priority
- Priority Number:
- 201862716356 P
- Priority Date:
- 08/08/2018
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C07K 16/28; C07K 16/30; C07K 16/46; A61K 39/39; A61P 35/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202413
- Publication date:
- 27/03/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202422
- Publication date:
- 29/05/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202423
- Publication date:
- 05/06/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|